Literature DB >> 10924253

Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons show increased susceptibility to cortical injury after focal cerebral ischemia.

T Saarelainen1, J A Lukkarinen, S Koponen, O H Gröhn, J Jolkkonen, E Koponen, A Haapasalo, L Alhonen, G Wong, J Koistinaho, R A Kauppinen, E Castrén.   

Abstract

It has been suggested that the increased production of endogenous BDNF after brain insults supports the survival of injured neurons and limits the spread of the damage. In order to test this hypothesis experimentally, we have produced transgenic mouse lines that overexpress the dominant-negative truncated splice variant of BDNF receptor trkB (trkB.T1) in postnatal cortical and hippocampal neurons. When these mice were exposed to transient focal cerebral ischemia by occluding the middle cerebral artery for 45 min and the damage was assessed 24 h later, transgenic mice had a significantly larger damage than wild-type littermates in the cerebral cortex (204 +/- 32% of wild-type, P = 0.02), but not in striatum, where the transgene is not expressed. Our results support the notion that endogenously expressed BDNF is neuroprotective and that BDNF signaling may have an important role in preventing brain damage after transient ischemia. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924253     DOI: 10.1006/mcne.2000.0863

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  20 in total

1.  Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats.

Authors:  Wanlu Du; Junbo Huang; Hailan Yao; Kechun Zhou; Bo Duan; Yizheng Wang
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 2.  Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Front Neuroendocrinol       Date:  2006-10-20       Impact factor: 8.606

Review 3.  The Physiology of BDNF and Its Relationship with ADHD.

Authors:  De-Yi Liu; Xue-Mei Shen; Fang-Fen Yuan; Ou-Yang Guo; Yan Zhong; Jian-Guo Chen; Ling-Qiang Zhu; Jing Wu
Journal:  Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.590

4.  Translational downregulation of the noncatalytic growth factor receptor TrkB.T1 by ischemic preconditioning of primary neurons.

Authors:  Julius A Steinbeck; Axel Methner
Journal:  Gene Expr       Date:  2005

5.  trkB-receptor activation contributes to the kainate-induced increase in BDNF mRNA synthesis.

Authors:  T Saarelainen; S Vaittinen; E Castrén
Journal:  Cell Mol Neurobiol       Date:  2001-08       Impact factor: 5.046

Review 6.  Brain-derived neurotrophic factor.

Authors:  Devin K Binder; Helen E Scharfman
Journal:  Growth Factors       Date:  2004-09       Impact factor: 2.511

7.  Differential regulation of BDNF, synaptic plasticity and sprouting in the hippocampal mossy fiber pathway of male and female rats.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Neuropharmacology       Date:  2013-05-06       Impact factor: 5.250

8.  Inhibition of BDNF signaling in the paraventricular nucleus of the hypothalamus lowers acute stress-induced pressor responses.

Authors:  Chris L Schaich; Theresa L Wellman; Zachary Einwag; Richard A Dutko; Benedek Erdos
Journal:  J Neurophysiol       Date:  2018-04-25       Impact factor: 2.714

9.  Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo.

Authors:  Laura Carim-Todd; Kevin G Bath; Gianluca Fulgenzi; Sudhirkumar Yanpallewar; Deqiang Jing; Colleen A Barrick; Jodi Becker; Hannah Buckley; Susan G Dorsey; Francis S Lee; Lino Tessarollo
Journal:  J Neurosci       Date:  2009-01-21       Impact factor: 6.167

10.  Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson's disease.

Authors:  Mark E Fenner; Cristian L Achim; Barbara Murray Fenner
Journal:  J Mol Histol       Date:  2013-12-29       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.